Management of pregnancies resulting from IVF fertilization: Consult #60 visual summary

From screening, to workup and treatment, find out how to provide the best course of action for your pregnant patients with anemia.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

Despite an increase in mifepristone use to manage early pregnancy loss over time, rates remain low, preventing patients from receiving proven benefits.

Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.

In a recent study, similar rates of adverse psychiatric-related outcomes were reported among patients with discontinuation of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors vs those without discontinuation.

In a recent study, cardiovascular severe maternal morbidity was significantly more common in patients with hypertensive disorders of pregnancy vs those without.